| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $273,365,439 ) (Continued on the next page) |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 002 | 2 | NIH | 9/18/2023 | $475,000 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 000 | 2 | NIH | 11/22/2022 | $568,868 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160761 | Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | 001 | 2 | NIH | 3/6/2023 | $63,998 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA271486 | Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis | 000 | 2 | NIH | 2/7/2023 | $481,745 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG071190 | Role of endothelium in pathogenesis of cerebral amyloid angiopathy | 000 | 3 | NIH | 6/12/2023 | $648,024 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG068206 | Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI | 000 | 3 | NIH | 6/30/2023 | $792,903 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AR076339 | Flexor tendon intrinsic healing and intervention strategy development | 000 | 3 | NIH | 7/31/2023 | $523,094 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK130884 | Pathobiology of Nonalcoholic Steatohepatitis | 000 | 3 | NIH | 7/12/2023 | $349,800 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01HL152967 | Therapeutic ECM Resorption in Cellular Systems and Precision Cut Lung Slices. | 000 | 3 | NIH | 11/23/2022 | $633,152 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R00AG058798 | Senescent Vascular Cells as Mediators of Cognitive Decline | 000 | 5 | NIH | 1/11/2023 | $249,000 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | UH3AG067593 | Non-pharmacological Options in postoperative Hospital-based And Rehabilitation pain Management (NOHARM) pragmatic clinical trial | 001 | 5 | NIH | 8/21/2023 | $1,396,360 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01NS113803 | Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models | 000 | 4 | NIH | 5/25/2023 | $623,080 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB028590 | Comprehensive characterization of coronary atherosclerotic disease using photon-counting-detector dual-source CT and its impact on patient management | 000 | 4 | NIH | 2/1/2023 | $673,521 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01CA246568 | Utility of memantine in preventing cognitive dysfunction in children receiving cranial radiotherapy | 000 | 4 | NIH | 7/14/2023 | $771,678 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AR074395 | Use of Chemically Modified RNA to Enhance Bone Healing | 000 | 5 | NIH | 8/21/2023 | $453,779 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG060920 | RISK OF COGNITIVE IMPAIRMENT AND DEMENTIA IN TOTAL JOINT ARTHROPLASTY | 001 | 5 | NIH | 4/24/2023 | $328,264 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK114007 | Mechanisms of alteration of gastrointestinal physiology by gut microbes | 002 | 7 | NIH | 7/24/2023 | $591,218 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK116231 | Glucagon secretion and action in humans | 002 | 7 | NIH | 6/28/2023 | $520,452 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01CA207183 | Palliating EGFR Inhibitor Rash in African American and Other Cancer Patients | 000 | 6 | NIH | 7/7/2023 | $1 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K12HD065987 | Mayo Clinic Building Interdisciplinary Research Careers in Women?s Health | 000 | 14 | NIH | 5/1/2023 | $745,476 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL092961 | Epithelial-Mesenchymal Interactions in Fibrosis Resolution | 002 | 13 | NIH | 5/23/2023 | $8,816 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | T32DK007013 | Kidney Disease Research Training Program | 001 | 45 | NIH | 9/27/2023 | $128,147 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K12CA090628 | Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic | 001 | 23 | NIH | 9/8/2023 | $674,416 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | T32GM145408 | MSTP at Mayo Clinic Rochester | 000 | 1 | NIH | 6/27/2023 | $1,161,070 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | UH3CA268103 | Development of machine learning software to quantitatively map telomere induced senescence in tissue sections during aging | 000 | 3 | NIH | 9/1/2023 | $722,010 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R56HL166204 | Ameliorating Synaptic and Mitochondrial Dysfunctions of the Respiratory Neuromotor System in Alzheimer's Disease | 001 | 1 | NIH | 9/21/2023 | $532,073 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL167354 | Cell-extrinsic emergency myelopoiesis regulated by ABCB7 | 000 | 1 | NIH | 7/7/2023 | $322,800 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R21AI178943 | Altered TCR signaling in anergy | 000 | 1 | NIH | 7/6/2023 | $242,100 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK133171 | An individualized medicine approach to urinary stone disease | 000 | 2 | NIH | 5/2/2023 | $552,665 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL166238 | Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection | 000 | 1 | NIH | 2/20/2023 | $395,436 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | P20DK135097 | Renal macrophages in the pathogenesis of human urinary stones and Randall's plaque formation in mice | 001 | 2 | NIH | 5/10/2023 | $394,105 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R34MH128296 | Evaluating the feasibility of a primary care-based treatment for restrictive eating disorders in children and adolescents | 000 | 1 | NIH | 2/13/2023 | $238,500 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R03AI170571 | Role of PAPP-A in Graves' Ophthalmopathy | 000 | 1 | NIH | 1/18/2023 | $79,500 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL151379 | Evaluating the natural evolution of myocardial stiffness in aging, sex differences, and through menopause transition in women, using a free-breathing magnetic resonance elastography approach | 000 | 1 | NIH | 12/20/2022 | $553,751 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | T32GM144233 | Predoctoral Training Program in Molecular Pharmacology | 001 | 2 | NIH | 8/22/2023 | $0 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 001 | 2 | NIH | 3/15/2023 | $50,565 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01DK129240 | Role of mitochondrial microRNAs (mitomiRs) in endogenous renal repair | 000 | 1 | NIH | 12/16/2022 | $472,014 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA259201 | Hereditary Genetics of Hepatocellular Carcinoma | 004 | 3 | NIH | 7/18/2023 | $39,041 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | UG3CA275669 | Spatially-resolved protein and transcriptome mapping of senescent cells | 001 | 2 | NIH | 8/1/2023 | $475,000 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R37CA272473 | De-implementation of inappropriate thyroid ultrasound | 000 | 2 | NIH | 6/13/2023 | $541,889 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL158548 | Novel Therapeutics for Cardiovascular Disease | 000 | 2 | NIH | 4/14/2023 | $693,407 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01HL160761 | Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | 000 | 2 | NIH | 11/23/2022 | $575,982 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01AG076163 | Regulation of the lymphoid cell fate by Hoxa9 | 000 | 2 | NIH | 1/4/2023 | $318,000 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | U01DK130181 | Liver Cirrhosis Network: Clinical Research Center - Mayo Clinic | 000 | 3 | NIH | 8/17/2023 | $100,000 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | K01DK129208 | Role of Small Extracellular Vesicles in Beta Cell Failure and Autoimmunity in Type 1 Diabetes Mellitus | 000 | 3 | NIH | 7/19/2023 | $153,068 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01EB030529 | FHIRCat: Enabling the Semantics of FHIR and Terminologies for Clinical and Translational Research | 000 | 3 | NIH | 1/27/2023 | $678,237 |
| | 2023 | 2023 | MAYO CLINIC | 200 1ST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM136869 | Molecular mechanistic studies of long ?noncoding? RNAs in mammalian cell differentiation | 002 | 3 | NIH | 8/1/2023 | $94,553 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM136869 | Molecular mechanistic studies of long ?noncoding? RNAs in mammalian cell differentiation | 001 | 3 | NIH | 3/10/2023 | $31,800 |
| | 2023 | 2023 | MAYO CLINIC | 200 FIRST ST SW | ROCHESTER | MN | 55905-0001 | OLMSTED | USA | R01GM136869 | Molecular mechanistic studies of long ?noncoding? RNAs in mammalian cell differentiation | 000 | 3 | NIH | 12/2/2022 | $286,200 |
|
